China proposes new FDA rules to speed up foreign drug approvals http://www.fiercepharma.com/pharma-asia/china-officially-process-to-speed-up-foreign-drug-approval Perhaps more dramatically, the new rules would allow foreign drugmakers to file for a new drug approval using data from international, multicenter trials, so long as those trials include China as a study site. Translation: No China-specific trial applications would be required for those foreign drugs. A new tailwind for bio?